Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-07-19
1999-09-21
Feise, Lila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514774, 435273, 524 22, 530356, 424435, A61K 4742, C07K 1107
Patent
active
059554380
ABSTRACT:
A collagen matrix comprise collagen fibrils which are cross-linked to one another by a reducing sugar or a reducing sugar derivative. The collagen matrix may be formed into a membrane useful in guided tissue regeneration.
REFERENCES:
patent: 4971954 (1990-11-01), Brodsky et al.
patent: 5700479 (1997-12-01), Lundgren et al.
Pachence (1996) J. BioMed. Mat. Res. 33: 35-40.
R.R. Kohn et al; Collagen Again In Vitro By Nonenzymatic Glycosylation And Browning; Diabetes, vol. 33, Jan. 1984; pp. 57-59.
M. J. C. Kent et al; Evidence For Glucose-Mediated Covalent Cross-Linking Of Collagen After Glycosylation In Vitro; Biochem. J; vol. 225; pp. 745-752; 1985.
Noff Matityahu
Pitaru Sandu
ColBar R & D Ltd.
Feise Lila
Pak Michael
LandOfFree
Collagen-based matrix does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Collagen-based matrix, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Collagen-based matrix will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-80295